Immunohistochemistry is required for patients with lymph node tissue hyperplasia due to malignant lesions to select appropriate chemotherapeutic agents and targeted drugs, and also to assess the severity of the disease.
Immunohistochemistry in the clinic refers to the application of the principle of immunology, the application of antigen-antibody reaction to determine the antigen in tissue cells through a chemical reaction to make the antibody’s chromogenic agent coloration, and its qualitative and quantitative study. It helps to improve the correct diagnostic rate in the differential diagnosis of poorly differentiated and undifferentiated malignant tumors.
Clinical immunohistochemical examination can also provide relevant treatment options, determine whether the patient is suitable for the use of chemotherapeutic drugs or targeted drug therapy, but also timely detection of small foci, the pathology of the tumor for further typing, to determine the primary site of metastatic malignant tumors and so on.
Therefore, for patients with lymph node tissue proliferation caused by malignant lesions, immunohistochemical examination is needed.